Compare SKWD & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SKWD | BHC |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.5B |
| IPO Year | 2022 | 1996 |
| Metric | SKWD | BHC |
|---|---|---|
| Price | $55.91 | $6.17 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 3 |
| Target Price | ★ $64.63 | $8.00 |
| AVG Volume (30 Days) | 412.3K | ★ 2.4M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 41.81 | ★ 423.08 |
| EPS | ★ 2.17 | N/A |
| Revenue | $1,416,541,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $29.54 | $4.61 |
| Revenue Next Year | $12.64 | N/A |
| P/E Ratio | $25.97 | ★ N/A |
| Revenue Growth | ★ 23.16 | N/A |
| 52 Week Low | $40.60 | $4.33 |
| 52 Week High | $65.69 | $8.00 |
| Indicator | SKWD | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 41.49 | 48.17 |
| Support Level | $54.02 | $6.14 |
| Resistance Level | $59.02 | $6.31 |
| Average True Range (ATR) | 1.53 | 0.29 |
| MACD | -0.18 | -0.08 |
| Stochastic Oscillator | 36.60 | 9.94 |
Skyward Specialty Insurance Group Inc is a specialty insurance company that offers a suite of specialized insurance solutions across specialty property and casualty markets on a non-admitted and admitted basis. Its portfolio of insurance offerings covers a wide variety of risks, including general liability, commercial auto, group accident and health, property, agriculture, credit, surety, and workers' compensation, among others. Geographically, the group mainly operates in the United States.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.